Literature DB >> 15517379

Effect of childhood obesity and obesity-related cardiovascular risk factors on glomerular and tubular protein excretion.

Katalin Csernus1, Eva Lanyi, Eva Erhardt, Denes Molnar.   

Abstract

UNLABELLED: There is increasing evidence that obesity may damage the kidney in otherwise healthy individuals. Our study investigated the effect of childhood obesity on urinary albumin and beta-2-microglobulin excretion, and the association of these with obesity-related cardiovascular risk factors. Random morning spot urine samples were collected from clinically healthy obese (n = 86; median age 12.9 years, range 8.9-17.2 years; median weight 80.6 kg, range 46.1-136.8 kg; median body mass index 30.4 kg/m2, range 24.5-43.2 kg/m2) and normal weight children (n = 79; median age 13.5 years, range 10.7-14.9 years; median weight 51.0 kg, range 27.3-72.5 kg; median body mass index 18.2 kg/m2, range 13.2-23.9 kg/m2). The obese children were examined for the presence of common obesity-related cardiovascular risk factors including hyperinsulinaemia, impaired glucose tolerance (IGT), dyslipidaemia, hypercholesterolaemia, and hypertension. Obese children had a significantly higher urinary albumin/creatinine ratio (U-ACR) (median 11.7 mg/g, interquartile range 12.9 mg/g versus median 9.0 mg/g, interquartile range 5.1 mg/g; P = 0.003) and urinary beta-2-microglobulin/creatinine ratio (U-BMCR) (median 63.9 microg/g, interquartile range 34.7 microg/g versus median 34.6 microg/g, interquartile range 44.1 microg/g; P < 0.001) than normal weight children. Among the obese children, the U-ACR was associated with fasting hyperinsulinaemia, IGT, and hypercholesterolaemia (all P < 0.05), and significantly correlated with the fasting (r = 0.23, P < 0.05) and 2-h (r = 0.37, P < 0.001) plasma glucose levels measured during an oral glucose tolerance test. Obese children with no more than one of the features of the metabolic syndrome had significantly lower U-ACRs than obese children with two or more features (median 10.4 mg/g, interquartile range 5.8 mg/g versus median 15.3 mg/g, interquartile range 14.9 mg/g; P < 0.05).
CONCLUSION: According to our results, clinically healthy obese children have a higher degree of albuminuria and beta-2-microglobulinuria than normal weight children, indicating early renal glomerular and tubular dysfunction as a consequence of childhood obesity. The urinary albumin/creatinine ratio in the obese children was associated with certain metabolic derangements linked to obesity, and also with the clustering of features of the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517379     DOI: 10.1007/s00431-004-1546-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  33 in total

1.  Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey.

Authors:  J S Yudkin; R D Forrest; C A Jackson
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

2.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

3.  Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1996-10       Impact factor: 7.124

Review 4.  The dysmetabolic syndrome.

Authors:  L Groop; M Orho-Melander
Journal:  J Intern Med       Date:  2001-08       Impact factor: 8.989

5.  Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity.

Authors:  H L Hillege; W M Janssen; A A Bak; G F Diercks; D E Grobbee; H J Crijns; W H Van Gilst; D De Zeeuw; P E De Jong
Journal:  J Intern Med       Date:  2001-06       Impact factor: 8.989

6.  Dissociation between urinary albumin excretion and variables associated with insulin resistance in a healthy population.

Authors:  I Zavaroni; L Bonini; P Gasparini; A Zuccarelli; E Dall'Aglio; L Barilli; F Cioni; A Strata; G M Reaven
Journal:  J Intern Med       Date:  1996-09       Impact factor: 8.989

7.  Association between microalbuminuria and the metabolic syndrome: NHANES III.

Authors:  Latha Palaniappan; Mercedes Carnethon; Stephen P Fortmann
Journal:  Am J Hypertens       Date:  2003-11       Impact factor: 2.689

8.  Renal haemodynamic studies in obesity hypertension.

Authors:  E Reisin; F G Messerli; H O Ventura; E D Frohlich
Journal:  J Hypertens       Date:  1987-08       Impact factor: 4.844

9.  Overexpression of mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase does not correct glucose-stimulated insulin secretion from diabetic GK rat pancreatic islets.

Authors:  K Ueda; Y Tanizawa; H Ishihara; N Kizuki; Y Ohta; A Matsutani; Y Oka
Journal:  Diabetologia       Date:  1998-06       Impact factor: 10.122

10.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06
View more
  25 in total

Review 1.  Impact of obesity on drug metabolism and elimination in adults and children.

Authors:  Margreke J E Brill; Jeroen Diepstraten; Anne van Rongen; Simone van Kralingen; John N van den Anker; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2012-05-01       Impact factor: 6.447

2.  Chapter 1: Definition and classification of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

3.  The population-based prevalence of albuminuria in children.

Authors:  Nicholas Larkins; Armando Teixeira-Pinto; Jonathan Craig
Journal:  Pediatr Nephrol       Date:  2017-07-27       Impact factor: 3.714

4.  Can childhood obesity influence later chronic kidney disease?

Authors:  Lyda Jadresic; Richard J Silverwood; Sanjay Kinra; Dorothea Nitsch
Journal:  Pediatr Nephrol       Date:  2018-11-10       Impact factor: 3.714

5.  Profiling proteinuria in pediatric patients.

Authors:  Carolyn L Abitbol; Jayanthi Chandar; Ali Mirza Onder; Obioma Nwobi; Brenda Montané; Gastón Zilleruelo
Journal:  Pediatr Nephrol       Date:  2006-05-20       Impact factor: 3.714

6.  Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES.

Authors:  Tatsuya Tominaga; Rajesh K Dutta; Darukeshwara Joladarashi; Toshio Doi; Janardan K Reddy; Yashpal S Kanwar
Journal:  J Biol Chem       Date:  2015-11-17       Impact factor: 5.157

7.  Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats.

Authors:  Kasi C McPherson; Lateia Taylor; Ashley C Johnson; Sean P Didion; Aron M Geurts; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-27

8.  Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents.

Authors:  Stephanie Nguyen; Charles McCulloch; Paul Brakeman; Anthony Portale; Chi-yuan Hsu
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

9.  Albumin excretion rate in normal adolescents: relation to insulin resistance and cardiovascular risk factors and comparisons to type 1 diabetes mellitus patients.

Authors:  Erin Rademacher; Michael Mauer; David R Jacobs; Blanche Chavers; Julia Steinke; Alan Sinaiko
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 8.237

Review 10.  Diabetic nephropathy in children and adolescents.

Authors:  Radovan Bogdanović
Journal:  Pediatr Nephrol       Date:  2007-10-17       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.